Literature DB >> 7461475

Spectrum of antibiotic-associated diarrhoea.

A H Lishman, I J Al-Jumaili, C O Record.   

Abstract

In an attempt to find the extent to which Clostridium difficile could be implicated as the cause of antibiotic-associated diarrhoea, the stools of 53 patients who had diarrhoea after a course of antibiotics were investigated for the presence of C. difficile toxin. Ten of the patients (19%) were found to be positive, but the stools of four out of 53 patients without diarrhoea after a course of antibiotics were also found to contain C. difficile toxin (7.5%). The titre of toxin in patients both with and without diarrhoea fell within the same range (up to 10(-5)). Neither the organism nor its toxin was found in the stool of 26 patients with ulcerative colitis, eight with Crohn's disease, 49 with non-specific diarrhoea, and 27 normal controls. We conclude that, while C. difficile is responsible for a proportion of cases of antibiotic-associated diarrhoea, the concentration of toxin is not the sole factor affecting the severity of this disorder.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7461475      PMCID: PMC1419297          DOI: 10.1136/gut.22.1.34

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  Ampicillin-associated diarrhea--A prospective study.

Authors:  F J Tedesco
Journal:  Am J Dig Dis       Date:  1975-04

Review 2.  Antibiotic-associated colitis.

Authors:  J G Bartlett
Journal:  Clin Gastroenterol       Date:  1979-09

3.  Gastrointestinal complications of antibiotic therapy.

Authors:  F R Fekety
Journal:  JAMA       Date:  1968-01-15       Impact factor: 56.272

4.  Law-medicine notes. Legal liability in clinical investigations.

Authors:  W J Curran
Journal:  N Engl J Med       Date:  1978-04-06       Impact factor: 91.245

5.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

6.  Undescribed toxin in pseudomembranous colitis.

Authors:  H E Larson; J V Parry; A B Price; D R Davies; J Dolby; D A Tyrrell
Journal:  Br Med J       Date:  1977-05-14

7.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

8.  Clostridium defficiel in the urogenital tract of males and females.

Authors:  S Hafiz; M G McEntegart; R S Morton; S A Waitkins
Journal:  Lancet       Date:  1975-02-22       Impact factor: 79.321

9.  Clostridium difficile associated diarrhoea: a role in inflammatory bowel disease?

Authors:  R P Bolton; R J Sherriff; A E Read
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

10.  Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin.

Authors:  G D Rifkin; F R Fekety; J Silva
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

View more
  10 in total

1.  Spontaneous persistent pseudomembranous colitis related to Clostridium difficile in ischaemic bowel disease.

Authors:  A Wu
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-29

2.  Antibiotic-associated colitis--the continuing saga.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-13

3.  Effect of a lactobacillus preparation on the absorption of oral ampicillin.

Authors:  R L Yost; V P Gotz
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

4.  Incidence and origin of Clostridium difficile in neonates.

Authors:  I J Al-Jumaili; M Shibley; A H Lishman; C O Record
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

5.  Asymptomatic neonatal colonisation by Clostridium difficile.

Authors:  R P Bolton; S K Tait; P R Dear; M S Losowsky
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

6.  Nosocomial diarrhoeas in a surgical division hyperendemic for Clostridium difficile: epidemiologic aspects emerging from an analysis of clinical records.

Authors:  P Urbano; S Le Brun
Journal:  Eur J Epidemiol       Date:  1986-12       Impact factor: 8.082

7.  Clostridium difficile and inflammatory bowel disease.

Authors:  C Greenfield; J R Aguilar Ramirez; R E Pounder; T Williams; M Danvers; S R Marper; P Noone
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

8.  Successful treatment with rifampin for fulminant antibiotics-associated colitis in a patient with non-Hodgkin's lymphoma.

Authors:  Kenichi Nomura; Yosuke Matsumoto; Naohisa Yoshida; Sawako Taji; Naoki Wakabayashi; Shoji Mitsufuji; Shigeo Horiike; Masuji Morita; Takeshi Okanoue; Masafumi Taniwaki
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

9.  Antibiotic associated colitis.

Authors:  S H Ahmad; P Kumar; S Fakhir; K N Ahmad; A Rattan; R S Channa; G Bajaj
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967

10.  Clostridium difficile toxin in acute diarrhoea complicating inflammatory bowel disease.

Authors:  M R Keighley; D Youngs; M Johnson; R N Allan; D W Burdon
Journal:  Gut       Date:  1982-05       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.